We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| KalVista Pharmaceuticals Inc | NASDAQ:KALV | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.29 | 2.76% | 10.78 | 241,417 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 9.99 | 11.33 | 10.81 | 10.26 | 10.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | -92.91M | -2.2022 | -4.90 | 454.79M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:20:01 | formt | 246 | 10.78 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/11/2023 | 12:13 | DJN | KalVista Pharma Hits Targeted Number of Patients in Sebetralstat Trial |
| 07/7/2023 | 17:51 | DJN | KalVista Pharmaceuticals Shares Rise 12%, Company Expects to Submit FDA.. |
KalVista Pharmaceuticals (KALV) Share Charts1 Year KalVista Pharmaceuticals Chart |
|
1 Month KalVista Pharmaceuticals Chart |
Intraday KalVista Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
